Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events.

PubWeight™: 3.26‹?› | Rank: Top 1%

🔗 View Article (PMID 17164456)

Published in JAMA on December 13, 2006

Authors

Leslie A Lange1, Christopher S Carlson, Lucia A Hindorff, Ethan M Lange, Jeremy Walston, J Peter Durda, Mary Cushman, Joshua C Bis, Donglin Zeng, Danyu Lin, Lewis H Kuller, Deborah A Nickerson, Bruce M Psaty, Russell P Tracy, Alexander P Reiner

Author Affiliations

1: Department of Genetics, University of North Carolina, Chapel Hill, NC 27599-7264, USA. leslie_lange@med.unc.edu

Articles citing this

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet (2009) 11.81

Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA (2009) 5.32

Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet (2008) 4.31

Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ (2011) 3.65

Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am J Hum Genet (2008) 3.61

Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations. Circulation (2009) 2.55

Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease. PLoS Med (2010) 1.89

A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation. PLoS Med (2010) 1.60

Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. Am J Psychiatry (2014) 1.60

Relationship of interleukin-6 with regional and global left-ventricular function in asymptomatic individuals without clinical cardiovascular disease: insights from the Multi-Ethnic Study of Atherosclerosis. Eur Heart J (2010) 1.58

Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control (2009) 1.52

Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study. Stroke (2008) 1.48

Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis. J Rheumatol (2013) 1.45

Evaluation of Hs-CRP levels and interleukin 18 (-137G/C) promoter polymorphism in risk prediction of coronary artery disease in first degree relatives. PLoS One (2015) 1.41

C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident coronary heart disease in two nested case-control studies. PLoS One (2008) 1.31

The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4,610 cases amongst 18,637 participants. PLoS One (2008) 1.28

A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke (2009) 1.20

IL-6 gene variation is associated with IL-6 and C-reactive protein levels but not cardiovascular outcomes in the Cardiovascular Health Study. Hum Genet (2007) 1.18

Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by Mendelian randomisation. Eur J Epidemiol (2008) 1.14

C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older. Cancer Causes Control (2009) 1.13

Epidemiology, heritability, and genetic linkage of C-reactive protein in African Americans (from the Jackson Heart Study). Am J Cardiol (2008) 1.10

Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study. PLoS One (2008) 1.09

IL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study. BMC Med Genet (2009) 1.06

Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis (2007) 1.05

Common variants in the CRP gene in relation to longevity and cause-specific mortality in older adults: the Cardiovascular Health Study. Atherosclerosis (2007) 1.01

The interaction of adiposity with the CRP gene affects CRP levels: age, gene/environment susceptibilty-Reykjavik study. Int J Obes (Lond) (2009) 1.00

Genome-wide association with C-reactive protein levels in CLHNS: evidence for the CRP and HNF1A loci and their interaction with exposure to a pathogenic environment. Inflammation (2012) 0.97

Elevated blood pressure, race/ethnicity, and C-reactive protein levels in children and adolescents. Pediatrics (2008) 0.96

External validity of the cardiovascular health study: a comparison with the Medicare population. Med Care (2009) 0.95

Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1beta and TNF genes in the Cardiovascular Health Study. J Atheroscler Thromb (2009) 0.95

Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence. Cancer Epidemiol Biomarkers Prev (2012) 0.94

Polymorphisms in the CRP gene moderate an association between depressive symptoms and circulating levels of C-reactive protein. Brain Behav Immun (2009) 0.94

Epidemiology of cytokines: the Women On the Move through Activity and Nutrition (WOMAN) Study. Am J Epidemiol (2008) 0.93

Biogeographic ancestry, self-identified race, and admixture-phenotype associations in the Heart SCORE Study. Am J Epidemiol (2012) 0.92

Molecular genetics of myocardial infarction. Genomic Med (2008) 0.91

Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agents. Clin Chem (2008) 0.90

Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the Health in Men Study. Int J Epidemiol (2009) 0.89

Association of exome sequences with plasma C-reactive protein levels in >9000 participants. Hum Mol Genet (2014) 0.88

C-Reactive protein gene variants are associated with postoperative C-reactive protein levels after coronary artery bypass surgery. BMC Med Genet (2009) 0.87

CRP polymorphisms and progression of chronic kidney disease in African Americans. Clin J Am Soc Nephrol (2009) 0.86

C-reactive protein + 1059 G>C polymorphism in type 2 diabetes and coronary artery disease patients. Meta Gene (2013) 0.85

Factors associated with arterial vascular events in PROFILE: a Multiethnic Lupus Cohort. Lupus (2009) 0.85

Genetic determinants of basal C-reactive protein expression in Filipino systemic lupus erythematosus families. Genes Immun (2008) 0.84

Genetics of C-reactive protein and complement factor H have an epistatic effect on carotid artery compliance: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol (2009) 0.84

Association of CRP gene polymorphism with CRP levels and Coronary Artery Disease in Type 2 Diabetes in Ahvaz, southwest of Iran. Bioimpacts (2014) 0.83

Inflammatory gene variants in the Tsimane, an indigenous Bolivian population with a high infectious load. Biodemography Soc Biol (2011) 0.83

Genetic variation in C-reactive protein (CRP) gene may be associated with risk of systemic lupus erythematosus and CRP concentrations. J Rheumatol (2008) 0.83

Effect of the rs2259816 polymorphism in the HNF1A gene on circulating levels of c-reactive protein and coronary artery disease (the ludwigshafen risk and cardiovascular health study). BMC Med Genet (2010) 0.82

Combinations of Polymorphic Markers of Chemokine Genes, Their Receptors and Acute Phase Protein Genes As Potential Predictors of Coronary Heart Diseases. Acta Naturae (2016) 0.82

CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients. Arthritis Res Ther (2014) 0.81

Association of the C-Reactive Protein Gene (CRP) rs1205 C>T Polymorphism with Aortic Valve Calcification in Patients with Aortic Stenosis. Int J Mol Sci (2015) 0.80

Fine-mapping the genetic basis of CRP regulation in African Americans: a Bayesian approach. Hum Genet (2008) 0.80

The role of gene variants of the inflammatory markers CRP and TNF-α in cardiovascular heart disease: systematic review and meta-analysis. Int J Clin Exp Med (2015) 0.79

CRP polymorphisms and chronic kidney disease in the third national health and nutrition examination survey. BMC Med Genet (2011) 0.79

C-reactive protein gene variants: independent association with late-life depression and circulating protein levels. Transl Psychiatry (2015) 0.78

Study of C-reactive protein and myocardial infarction in the Indian population. Indian J Clin Biochem (2011) 0.78

Testing concordance of instrumental variable effects in generalized linear models with application to Mendelian randomization. Stat Med (2014) 0.78

C-reactive protein and risk of colorectal adenomas or serrated polyps: a prospective study. Cancer Prev Res (Phila) (2014) 0.78

Multiancestral analysis of inflammation-related genetic variants and C-reactive protein in the population architecture using genomics and epidemiology study. Circ Cardiovasc Genet (2014) 0.77

CRP gene variation and risk of community-acquired pneumonia. Respirology (2009) 0.77

C-reactive protein haplotypes and dispositional optimism in obese and nonobese elderly subjects. Inflamm Res (2011) 0.77

Haplotypes in the CRP gene associated with increased BMI and levels of CRP in subjects with type 2 diabetes or obesity from Southwestern Mexico. Exp Diabetes Res (2012) 0.77

Effects of guideline-oriented pharmacotherapy in patients with newly diagnosed COPD: a prospective study. Wien Klin Wochenschr (2013) 0.76

Association between CRP and TNF-α genes Variants and Cardiovascular Heart Disease in a Mexican Population: Protocol for a Case-Control Study. Int J Environ Res Public Health (2016) 0.76

Polymorphisms in the CRP gene and cardiovascular events. JAMA (2007) 0.75

Circulating neuregulin 4 levels are inversely associated with subclinical cardiovascular disease in obese adults. Sci Rep (2016) 0.75

Association of inflammatory gene polymorphisms with mechanical heart valve reoperation. Springerplus (2016) 0.75

The role of genetic variants in CRP in radiographic severity in African Americans with early and established rheumatoid arthritis. Genes Immun (2015) 0.75

CRP-level-associated polymorphism rs1205 within the CRP gene is associated with 2-hour glucose level: The SAPPHIRe study. Sci Rep (2017) 0.75

Articles by these authors

Finding the missing heritability of complex diseases. Nature (2009) 67.95

Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol (2002) 35.63

Targeted capture and massively parallel sequencing of 12 human exomes. Nature (2009) 33.96

Exome sequencing identifies the cause of a mendelian disorder. Nat Genet (2009) 32.06

Mapping and sequencing of structural variation from eight human genomes. Nature (2008) 30.28

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation (2003) 23.97

Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74

Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet (2003) 21.52

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38

Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science (2012) 17.12

Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature (2012) 14.76

Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet (2011) 14.29

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology (2005) 13.05

Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet (2010) 12.63

Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44

Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09

Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med (2010) 11.99

Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet (2011) 11.94

Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14

Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med (2003) 10.06

Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52

Automating sequence-based detection and genotyping of SNPs from diploid samples. Nat Genet (2006) 9.04

Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature (2012) 8.91

Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med (2005) 8.77

Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73

Estrogen therapy and coronary-artery calcification. N Engl J Med (2007) 8.70

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.65

Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci (2006) 8.00

Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94

Mapping complex disease loci in whole-genome association studies. Nature (2004) 7.31

Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2011) 7.30

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA (2013) 7.19

Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One (2008) 7.16

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA (2010) 7.12

Population history and natural selection shape patterns of genetic variation in 132 genes. PLoS Biol (2004) 7.11

Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood (2009) 7.00

Evidence for substantial fine-scale variation in recombination rates across the human genome. Nat Genet (2004) 6.99

Population analysis of large copy number variants and hotspots of human genetic disease. Am J Hum Genet (2009) 6.79

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med (2006) 6.58

Frailty consensus: a call to action. J Am Med Dir Assoc (2013) 6.54

Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 6.51

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

Massively parallel exon capture and library-free resequencing across 16 genomes. Nat Methods (2009) 6.36

A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34

Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science (2012) 6.21

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA (2011) 6.10

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet (2009) 6.04

Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA (2008) 6.00

Lifetime risks of cardiovascular disease. N Engl J Med (2012) 5.95

HIV infection and the risk of acute myocardial infarction. JAMA Intern Med (2013) 5.90

Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med (2008) 5.86

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med (2012) 5.49

Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am J Hum Genet (2012) 5.48

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48

Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med (2014) 5.47

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA (2005) 5.46

Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis (2010) 5.35

Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans. Nat Genet (2003) 5.30

Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol (2011) 5.30

Genomewide association studies of stroke. N Engl J Med (2009) 5.29

Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol (2006) 5.28

Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet (2009) 5.20

Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation (2011) 5.16

Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.02

Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med (2002) 4.97

Inflammation as a risk factor for atrial fibrillation. Circulation (2003) 4.95

Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med (2014) 4.94

Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol (2013) 4.85

Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimers Dement (2010) 4.85

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA (2013) 4.85

Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol (2003) 4.82

Genomic regions exhibiting positive selection identified from dense genotype data. Genome Res (2005) 4.81

Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med (2009) 4.80